SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending after reporting substantial revenue growth and positive adjusted EBITDA, coupled with increased capacity guidance and the strategic acquisition of AI agentic search company Tavily. The community is actively debating whether these strong operational metrics and strategic moves outweigh a perceived earnings miss, positioning NBIS as a highly discussed AI infrastructure play amid intense sector demand.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending after announcing its oral obesity drug, VK2735, will advance directly to Phase 3 trials in Q3 2026, significantly accelerating its market timeline and drawing community discussion around its strong clinical pipeline. This accelerated development, coupled with ongoing Phase 3 trials for its injectable version and a robust cash position, fuels community sentiment that the company is undervalued and a prime acquisition target, especially amid recent regulatory scrutiny on compounded GLP-1 alternatives.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending following the U.S. FDA approval of its Optune Pax, a Tumor Treating Fields therapy for locally advanced pancreatic cancer, hailed as the first new treatment in three decades with improved patient outcomes. The community is actively debating significant upside potential from this groundbreaking news, while some caution about previous stock volatility and potential commercial challenges, despite promising survival and pain progression data from trials.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape's new Eagle Line pilot production facility and ongoing B-sample shipments to automotive OEMs are sparking intense community discussion. Investors are actively debating the company's path to commercialization and eagerly anticipating concrete partnership announcements for its solid-state battery technology.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending due to the impending shareholder vote to merge with Infleqtion, a quantum technology leader that recently secured high-profile contracts with NASA for space sensing and the U.S. Department of Energy for energy grid optimization. The community is actively debating Infleqtion's significant undervaluation compared to its peers and its robust real-world applications, though some express caution given the SPAC sponsor's past performance.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending following its strong Q4 earnings, beat-and-raise guidance, and new $1 billion share buyback, yet the stock is experiencing a sharp sell-off, prompting intense community debate over whether analyst price target cuts and pervasive "AI disruption" fears are unjustly punishing the SaaS sector.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly (FSLY) is surging after reporting record Q4 and full-year 2025 financial results, achieving significant revenue growth, improved gross margins, and a return to profitability, alongside an optimistic 2026 outlook. The community is highlighting the company's turnaround, citing strong security revenue and AI-driven tailwinds as key growth drivers, with many believing the stock remains undervalued despite the sharp move.

MNDE is the governance token for Marinade. Marinade helps you to stake Solana without locking in liquidity by turning SOL into mSOL - tokenized version of staked SOL. This way you can both secure the network by staking SOL, and use your mSOL as the ultimate unit in Solana DeFi ecosystem. To provide liquidity, deposit in lending protocols and even buy NFTs.

Marinade

Marinade (MNDE) is trending as the community widely discusses its significant undervaluation, highlighting its substantial Total Value Locked (TVL) on the Solana blockchain relative to its market capitalization, positioning it as a leading liquid staking platform poised for a potential breakout.

Crocs, Inc. engages in the design, development, manufacture, worldwide marketing, sale, and distribution of lifestyle footwear and accessories. It operates through the Crocs Brand and HEYDUDE Brand segments. The company was founded by Scott Seamans, George B. Boedecker, Jr., and Lyndon V. Hanson III in 2002 and is headquartered in Broomfield, CO.

Crocs Inc

Crocs is trending following an unexpected adjusted earnings and revenue beat, defying earlier market pessimism and driving a significant rally. Community sentiment highlights the stock's perceived undervaluation, ongoing share buybacks, and signs of stabilization in its HeyDude brand as key drivers, despite broader sector headwinds.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is actively discussed following its robust Q4 revenue performance and an expanded $500 million share buyback authorization, despite a conservative 2026 EPS outlook. Community members are weighing leadership changes and the significant potential from new ICE contracts for monitoring and skip tracing services against recent stock performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PFE Bullish options activity is heating up after that Q4 double beat. 📈 While the market digests the Metsera tolerability data, the oncology moat from Seagen is already delivering 14% growth. Dividend yield remains a fortress at nearly 6% while we wait for the 2028 growth pivot. The &quot;TrumpRx&quot; initiative is a smart geostrategy play to front-run pricing regs. Watching the $30 resistance level closely. 🐂💎 
 
 #Pfizer #StockMarket #Pharma #Growth 
 
Risk Warning: CFDs are high-risk. 77.95% of retail accounts lose money.

StockTwits Web

Pfizer Inc

 Bullish options activity is heating up after that Q4 double beat. 📈 While the market digests the Metsera tolerability data, the oncology moat from Seagen is already delivering 14% growth. Dividend yield remains a fortress at nearly 6% while we wait for the 2028 growth pivot. The "TrumpRx" initiative is a smart geostrategy play to front-run pricing regs. Watching the $30 resistance level closely. 🐂💎 
 
 